Therapeutics: Solute carrier family 2 facilitated glucose transporter member 1 (SLC2A1; GLUT1); AMP-activated protein kinase (AMPK); mitochondrial complex 1 (MC

Patient sample, cell culture and mouse studies suggest inhibiting SLC2A1, AMPK or MC-1 could help treat T cell ALL. Levels of the glucose transporter SLC2A1 were higher in T cells from T cell ALL pati...